NDC 70377-038

POSACONAZOLE

Posaconazole

POSACONAZOLE is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Biocon Phama Inc.. The primary component is Posaconazole.

Product ID70377-038_b7a2fd29-83b5-6ae6-775c-98f91a6c0ea4
NDC70377-038
Product TypeHuman Prescription Drug
Proprietary NamePOSACONAZOLE
Generic NamePosaconazole
Dosage FormTablet, Delayed Release
Route of AdministrationORAL
Marketing Start Date2022-03-08
Marketing CategoryANDA /
Application NumberANDA214476
Labeler NameBiocon Phama Inc.
Substance NamePOSACONAZOLE
Active Ingredient Strength100 mg/1
Pharm ClassesAzole Antifungal [EPC], Azoles [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 70377-038-11

60 TABLET, DELAYED RELEASE in 1 BOTTLE (70377-038-11)
Marketing Start Date2022-03-08
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "POSACONAZOLE" or generic name "Posaconazole"

NDCBrand NameGeneric Name
0254-2045POSACONAZOLEposaconazole
0406-7711POSACONAZOLEposaconazole
0527-2133POSACONAZOLEPosaconazole
60687-523PosaconazolePosaconazole
70748-258POSACONAZOLEPOSACONAZOLE
0085-1328NOXAFILposaconazole
0085-2224NOXAFILposaconazole
0085-4324NOXAFILposaconazole
0085-4331NOXAFILposaconazole

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.